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Abstract As concerns the microscopic morphology of ductal
carcinoma in situ (DCIS), neoplastic cells are surrounded by
both a myoepithelial cell layer and a basement membrane as
expected from the outer structure of ducts and lobules.
However, in some cases, it is impossible to state whether the
structures involved by the disease are ducts or lobules.
Altogether 1220 anatomic structures involved by DCIS
displaying comedo necrosis from 27 slides of 21 patients (seen
on both haematoxylin and eosin-stained and orcein-stained
slides) were identified as representing ducts, likely ducts, un-
classifiable structures, likely acini or acini on the basis of their
distribution and resemblance to normal anatomic structures.
All structures were then rated as having a circumferential elas-
tic layer (as normal ducts), a partial elastic layer around more
or less than half of the periphery or having no peripheral
elastic layer at all (as normal acini). Structures classified as
ducts or likely ducts were likely to have an elastic coating,
whereas acini and likely acini had no such coating.
Unclassifiable structures were generally devoid of an elastic
layer. Structures (and cases) that were likely to represent
neoductgenesis as proposed by Zhou et al. (Int J Breast
Cancer 2014;2014:581706) were generally unclassifiable
and devoid of outer elastic layer. Many duct-like structures
in DCIS with comedo necrosis are devoid of elastic layer
typical of normal ducts, suggesting that these structures are
abnormal despite conservation of the myoepithelium and the
basement membrane.
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Introduction
Breast parenchyma is organised into anatomic units corre-
sponding to mammary lobes. A lobe can be defined as the
complex of a lactiferous duct branching into smaller and
smaller ducts with terminal ductules and the lobule forming
acini belonging to these ductules at the end, i.e. each lactifer-
ous duct defines a different lobe, of which 15 to 25 make up
the breast parenchyma [1]. An easy to imagine visual analogy
of the lobar organisation would be that of a tree, where the
lactiferous duct would correspond to the trunk, the ducts to
branches and the lobules to compound leaves. The outer
myoepithelial layer and the basement membrane around the
ducts would represent the bark of the tree. Acini of the lobules
and ducts are easy to distinguish from each other. However,
when their lumen enlarges and the diameter becomes larger,
ectatic ducts and cystically dilated acini are not always easy to
separate. The maintained lobular architecture, multiplicity of
the lumens and the common presence of apocrine epithelium
helps to identify dilated lumina as cysts. In contrast to cysts,
ectatic ducts are generally single or separated from each other
by normal breast adipose or fibrous tissue more in keeping
with interlobular stroma than with intralobular stroma.
Although both the ducts and lobules feature an outer
myoepithelial cell layer and a basement membrane, there is
usually also an elastic layer around the ducts, which is missing
around the acini (Fig. 1). This phenomenon can also help in
the distinction between ectatic ducts or cystic acini, although
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the amount of elastic fibres around dilated ducts is dependent
on the amount initially present and any damage by inflamma-
tory processes (Fig. 1) [2].
When ductal carcinoma in situ (DCIS) develops in the duc-
tal tree or its end, the terminal ductulolobular unit (TDLU),
there is often a dilatation of the normal anatomic structures.
When the anatomy of the breast is maintained, DCIS can
easily be identified as involving the ducts and sometimes the
lobules. The latter phenomenon has been called cancerisation
of lobules or lobular cancerisation [3, 4] (Fig. 1b). The anal-
ogy of the tree also applies to this presentation.
Some forms of DCIS do not follow this regular growth and
intraluminal spread. Instead, there are plenty of more or less
dilated lumens dispersed with a relatively uniform and higher
than normal density. Although some believe that this pattern is
also due to abnormal extent of dilatation of preexisting struc-
tures (i.e. ducts and lobules) like overinflated balloons touch-
ing each other, there is apparently no obviously discernible
lobular archi tecture maintained. The concept of
neoductgenesis has been introduced to explain the morpholo-
gy of these cancers [5, 6]. This concept suggests that new
ducts are formed from the preexisting ones and grow into
the stroma. Keeping the analogy of the tree, this would corre-
spond to new lateral branches starting to grow from the trunk
or other larger branches, keeping the characteristic feature of
branches, i.e. having their bark. Indeed, the structures identi-
fied under the microscope in such cases have a myoepithelial
layer and a basement membrane and are easy to interpret as
DCIS, although myoepithelial phenotype and myoepithelial
marker expression may be altered [7, 8]. Newly formed ducts
‘invade’ the stroma in a pushing manner without losing their
myoepithelial and basement membrane layers which are the
diagnostic hallmark of in situ carcinomas and the clue used to
exclude the presence of invasion in breast pathology. This
controversy is certainly the cause why the concept of
neoductgenesis is not widely accepted, despite having more
and more advocates. Neoductgenesis could explain the ag-
gressive behaviour of tumours with this phenomenon having
minor areas of classical invasive carcinoma of no special type
(interpreted as ductal carcinomas with extensive intraductal
component). Such tumours have a larger whole tumour size
(including the DCIS morphology) than invasive tumour size
(including only the smaller classical invasive carcinoma), and
when stratified according to other prognosticators, their sur-
vival curves match those of no special type invasive tumours
of which the size corresponds to the whole tumour size of
tumours with neoductgenesis rather than their classical inva-
sive tumour size [5, 6]. The phenomenon could also be an
explanation for the anecdotal cases where no classical inva-
sive tumour is identified near DCIS with features of
neoductgenesis, but the patient dies of breast cancer [6].
Local recurrence rates in cases diagnosed as representing pure
DCIS are also higher in neoplasms with proposed
neoductgenesis, and this is also related to their greater exten-
sion and diffuse growth pattern [9, 10] but also reflects a
worse overall prognosis.
Neoductgenesis is not easy to define. It has been associated
with casting (linear branching) type calcifications on the
mammogram, and tumours with this manifestation have been
reported to have poor outcome in several series [5, 11–14]
with some contradicting results in others [15–17]. Tenascin
expression has been demonstrated around the newly formed
ducts [5, 6]. Morphologic criteria have also been proposed on
the basis of duct concentration, periductal fibrosis and lym-
phocytic infiltration [18] and may help to identify cases with
this phenomenon even on histological slides.
Fig. 1 Elastic fibres around normal and dilated anatomic structures. a A
duct with elastic coating (arrow) and acini without an outer elastic layer
arranged into lobules. b Lobular cancerisation. DCIS extending into a
lobule without altering the lack of elastic fibres around lobule forming
acini. c Closely packed cysts devoid of elastic fibres. d Ectatic duct with
maintained elastic coating (arrows). (Orcein, ×10, ×10, ×8, ×15)
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In the present study, we analysed lumen forming structures
of the DCIS component of a few tumours (some of which
were believed to represent DCIS with neoductgenesis) with
orcein staining with the aim to see how ducts and acini main-
tain their staining when involved by DCIS and to see how
ducts believed to be newly formed behave with this stain.
Material and methods
Selected histological slides of patients with areas of DCIS
(mostly associated with areas of invasive cancer) demonstrat-
i n g comedo nec r o s i s a nd c en t r a l , amo rphou s
microcalcification on histology slides were retrospectively
analysed. The study cases were from the Pathology
Departments of the University of Szeged (collected from a
consecutive series of patients with radiologic evidence of cast-
ing (linear branching) type calcification) and the Bács-Kiskun
County Teaching Hospital (randomly selected cases with
comedo necrosis and central amorphous calcification in the
slides; these were from a previous pilot study looking at the
elastic stains).The clinicopathological information needed
was obtained from the radiological and histopathological
reports.
Inclusion criteria were the following: casting (linear
branching) type calcification described by the radiological
report or the histopathology report, high or intermediate
grade DCIS [19] with or without invasive breast carcino-
ma, resected tumour specimens and availability of slides
and paraffin blocks. For control, two slides with normal
breast tissue and architecture (derived from non-tumorous
random samples of resections performed for breast can-
cer) were included in the study.
Haematoxylin and eosin (HE) staining was employed for
the identification of anatomic structures involved by the in situ
neoplastic cells as ducts or acini, whereas orcein staining
alone or combined with haematoxylin or HE (ORC) was used
for the evaluation of elastic fibres around the units previously
classified on the basis of the HE stain. One or two slides per
case were selected and digitised with a 3DHistec Pannoramic
250 Flash III scanner.
In the first step, with the aid of the freely downloadable
Pannoramic Viewer software (3DHistec, Budapest, Hungary),
the structures were numbered in parallel on both the HE and
the ORC digital slides (Fig. 2).
Each numbered structure that could be identified on both
HE and ORC stained slides was then classified into one of the
following categories: definitely representing a duct, likely to
be a duct, unclassifiable, likely to be an acinus, and definitely
representing an acinus (Fig. 2). For this classification, the
resemblance to the normal microanatomical structures was
considered, i.e. clustered arrangement into or resemblance to
lobular structures pointing to acinar structures and single
structures pointing to a ductal nature.
The elastic fibres around the numbered and classified struc-
tures were graded as concentric presence (score 3), dominant
presence (continuous or discontinuous elastic fibres around
more than half of the perimeter of the structure; score 2),
dominant absence (focal, elastic fibres around less than half
of the perimeter of the structure; score 1) and absence of elas-
tic fibres around the structure (score 0) (Fig. 3).
The neoductgenesis score described by Zhou et al. [18]
was applied for the identification of tumours demonstrat-
ing neoductgenesis. (The cases were selected before this
description was read). This scoring system takes into ac-
count the concentration of duct-like structures and loss of
normal ductal-lobular architecture, the lymphocytic
Fig. 2 Annotated structures. Structures that could be identified on both HE and ORC slides were numbered and classified as ducts (a), likely ducts (b),
unclassifiable structures (c), likely acini (d) or acini (e)
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infiltration and periductal fibrosis (Table 1). The original
description of the score also includes a visual scale for
each score component, and this was used to label the
cases. However, we also applied the score to individual
structures. For this, we used the first component of the
combined score from the entire slide, but the two remain-
ing score components were derived from the lymphocytic
infiltration and fibrosis around the given structure.
The statistics included the Mann-Whitney and the chi-
square tests. All statistical tests were two-sided, and
p < 0.05 values were considered statistically significant.
The institutional ethical committee of the Bács-Kiskun
County Teaching Hospital was consulted and raised no con-
cerns about this non-interventional retrospective study.
Results
Twenty-seven slides from 21 female patients were inves-
tigated in this retrospective study (median 1 slide/case).
The mean age of the patients was 63.7 (range 46–86). The
basic clinicopathological parameters are displayed in
Table 2. Two thirds of the patients had high grade DCIS
with invasive carcinoma of no special type. The
mean ± S.D. invasive tumour size and tumour extension
(including DCIS as well) were 13.9 ± 17.7 mm (range = 0–
65 mm) and 44.4 ± 30.7 mm (range = 12–65 mm), re-
spectively. The invasive component showed almost exclu-
sively high nuclear grade. The in situ component was of
high grade in all but one case. Oestrogen receptor and
progesterone receptor positivity were observed in 13 cases
and 11 cases, respectively. Intense, concentric membra-
nous positivity of human epidermal growth factor
receptor-2 (HER-2) was seen in 13 cases (61.9%).
Centrally calcified comedo type necrosis was present in
all cases, and casting (linear branching) type calcification
on the mammogram was documented in 17 cases; two
cases had mammography elsewhere and no data on the
type of calcifications were available, and two cases had
Fig. 3 Scoring of the elastic layer around anatomical structures. a
Concentric presence (score 3). b Dominant presence (continuous or
discontinuous elastic fibres around more than half of the perimeter of
the structure; score 2). c Dominant absence (focal, elastic fibres around
less than half of the perimeter of the structure; score 1). d Complete or
nearly complete absence of elastic fibres around the structure (score 0)
Table 1 Neoductgenesis score [18]
Variable Score
Concentration of duct-like structures
and loss of normal ductal-lobular
architecture
Absent 0
Focal 1
General 2
Periductal lymphocytic infiltration
Absent 0
Mild 1
Pronounced 2
Periductal fibrosis
Absent 0
Mild 1
Pronounced 2
Neoductgenesis Score
Present 5–6
Absent 0–4
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granular rather than casting type calcification described in
the radiological report.
Altogether 1220 structures were classified as ducts or acini
with different levels of certitude, as described in the ‘Material
and methods’. The majority (nearly two thirds) were unclas-
sifiable, and between 7.4 and 13.6% belonged to one of the
four remaining categories each. The relation of these classified
structures to peristructural elastic fibres is shown in Table 3.
The concentric presence of elastic fibres is more frequent
around structures identified as ducts or likely ducts but was
also seen around a minority of unclassifiable structures. At the
opposite end of the spectrum, acini lack elastic fibres around,
similarly to likely acini. Most unclassifiable structures are also
completely or partially (dominant absence pattern) devoid of
peristructural elastic fibres (Fig. 4).
Ducts (n = 33) and acini (n = 150) of control breast
slides were also analysed for the presence of elastic coat-
ing around these normal structures. The Mann-Whitney
test revealed significant difference between ducts and ac-
ini: a concentric elastic fibre layer surrounds almost all
normal ducts, but the acini do not have such an elastic
coating (p < 0.001).
Neoductgenesis was identified in six (25.5%) cases by
using the neoductgenesis score suggested by Zhou and
coworkers. After the application of this scoring system
to a l l numbe red s t ruc tu r e s , we found tha t i n
neoductgenesis positive tumours, 27.3% of the numbered
units were suggested as neoducts and there was hardly
any potential neoducts (0.75%) in neoductgenesis nega-
tive tumours.
We examined the means of the scores of numbered individ-
ual structures per case, as well. In neoductgenesis positive tu-
mours (n = 6), the average of the neoductgenesis-related scores
was higher (mean ± S.D. = 3.87 ± 0.35, range = 3.49–4.39) than
in neoductgenesis negative cases (mean ± S.D. = 1.97 ± 1.11,
range = 0–3.1).
Two third of these neoducts identified by the per struc-
ture scoring system are irregular and uncertainly classifi-
able structures (Table 4) and almost 80% of them are not
or dominantly not surrounded by elastic fibres. The chi-
square test revealed a significant difference between the
normal structures and the individual score based neoducts:
the latter generally do not have an elastic layer around
(p < 0.001).
In neoductgenesis positive and negative tumours, the pres-
ence of elastic fibres was evaluated by scoring of each struc-
ture on orcein-stained slides as described in the ‘Material and
methods’. Lower scores were found in the neoductgenesis
positive tumours (mean ± S.D. = 0.57 ± 0.32, range = 0.28–
0.91) than in neoductgenesis negative neoplasms
(mean ± S.D. = 0.89 ± 0.54, range = 0.1–2.1).
Table 2 Basic clinicopathological information in the cases studied
Specimen
Mastectomy 9 (42.8%)
Breast-conserving surgery 12 (57.2%)
Histological diagnosis
Pure DCIS 9 (42.8%)
DCIS with invasive carcinoma 12 (57.2%)
Oestrogen receptor
Positive 13 (61.9%)
Negative 8 (38.1%)
Progesterone receptor
Positive 11 (52.3%)
Negative 10 (47.7%)
HER-2
3+ 11 (52.3%)
2+ 1 (4.8%)
1+ 1 (4.8%)
Negative 8 (38.1%)
DCIS ductal carcinoma in situ, HER-2 human epidermal growth factor
receptor-2
Table 3 The proportions of
elastic fibres around the evaluated
structures
Duct vs. acinus Elastic fibres All (n) All (%)
Absence Dominant
absence
Dominant
presence
Concentric
presence
n % n % n % n %
Duct 5 0.4 9 0.7 24 1.9 53 4.4 91 7.4
Likely duct 21 1.3 34 2.9 25 2 33 2.7 113 8.9
Unclassifiable 559 45.9 142 11.7 36 3.1 25 2 762 62.7
Likely acinus 88 7.3 1 0.07 1 0.07 0 0 90 7.44
Acinus 162 13.4 2 0.16 0 0 0 0 164 13.56
All 835 68.3 188 15.53 86 7.07 111 9.1 1220 100
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Discussion
Our study of a large number of breast microanatomic
structures suggests that most of the densely packed struc-
tures involved by morphological DCIS with comedo ne-
crosis cannot be classified on the basis of the HE look as
ducts or acini. The study of the control cases reinforced
the known microanatomy of ducts and lobules, of which
only the previous have an elastic coating. The study also
demonstrated that DCIS involved structures that could be
classified as ducts or acini with some certainty displayed
the elastic coating expected on the basis of the normal
anatomic structures. On the other hand, most structures
that could not be reliably classified as ducts or acini, in
parallel with most structures classified as representing
neoducts on the basis of the proposed scoring system
[18] adapted to the individual structures, were devoid of
an elastic coating. Although this could be used as a sup-
port to the acinar origin of these structures, it is more
realistic to suggest that together with previously described
stromal periductal tenascin-C accumulation [5, 6], this
could be another difference between preexisting and new-
ly formed ducts. It is not known whether the proposed
new ducts are devoid of periductal elastic fibres from
the beginning or these fibres are lost as a consequence
of periductal inflammation and/or fibrosis.
Myoepithelial cells have been reported to have an altered
phenotype in some DCIS cases, characterised by the loss of
one or more myoepithelial markers labell ing the
myoepithelium around normal anatomic mammary structures.
The phenomenon occurs more frequently in high grade DCIS.
None of the present cases were of low grade, and all but one
case were of high grade. Although we did not study the ex-
pression of myoepithelial markers, we detected another
Fig. 4 Elastic fibres around ducts
involved by DCIS, and their
absence around similar structures,
that could represent neoducts but
do not reach an individual score
for the qualification as neoduct in
a neoductgenesis negative case on
the basis of the overall score
(Orcein, ×4). Note the branching
of the elastic fibre-negative
structure from the elastic fibre-
positive duct
Table 4 The morphological
characteristics of potential
neoducts (n = 218)
Neoduct Elastic fibres All
(n)
All
(%)
Absence Dominant
abscense
Dominant
presence
Concentric
presence
n % n % n % n %
Duct 3 1.4 5 2.4 5 2.4 15 6.9 28 13.1
Likely duct 5 2.4 13 6.2 9 4.2 5 2.4 32 15.2
Unclassified 109 50 20 9.3 5 2.4 5 2.4 139 64.1
Likely
acinus
8 3.7 1 0.6 0 0 0 0 9 4.3
Acinus 7 3.3 0 0 0 0 0 0 7 3.3
All 132 60.8 39 18.5 19 9 28 11.7 218 100
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abnormality of high grade DCIS cases with comedo necrosis,
namely the lack of elastic fibres around the ducts. This was not
only present in cases which displayed a neoductgenesis score
above 4 but also in cases with lower scores.
Neoductgenesis is a concept to explain the morphology of
certain breast cancers that show neoplastic cells in densely
packed anatomic structures seemingly corresponding to either
normal ducts or acini on the basis of the presence of a base-
ment membrane and a myoepithelial layer at the outer surface
but not corresponding to any of these preexisting structures
when looking at the lack of the tree-like distribution of normal
anatomic structures described in the ‘Introduction’. The theo-
ry suggests that some breast carcinomas are characterised by
the outgrowth of new branches, i.e. new ducts, neoducts from
the ductal tree, representing a pushing type infiltration.
Densely packed, tumour involved, myoepithelium coated
structures could theoretically represent engulfed preexisting
acini (and ducts), but when one looks at the phenomenon of
lobular cancerization, where this neoplastic inflation happens,
or at ductectasia or cystic changes where dilation of
preexisting lumina generally occurs without intraluminal epi-
thelial proliferation, it is clear that these processes maintaining
the tree-like structure are different from cancers with pre-
sumed neoductgenesis. Three-dimensional analysis of such
cases further reinforces the lack of normal distribution of ducts
and acini in such tumours [6]. This ‘disturbed arborisation’ [9,
10] could be the result of a disturbed alveolar switch [20], a
hormonally driven physiologic mechanism responsible for the
development of acini from ductal epithelium. Our report indi-
cates that the proposed neoducts are also devoid of elastic
coating, resembling acini in this respect.
There were more structures that could not be reliably clas-
sified as ducts or acini than structures corresponding to
neoducts on the basis of the neoduct scoring applied to the
individual structures. These unclassifiable structures were
generally devoid of elastic fibres. Cases that could not be
classified as representing neoductgenesis on the basis of the
overall score also contained such elastic fibreless unclassifi-
able structures. It could happen that more of these comedo
necrotic structures correspond to neoducts than those identi-
fied as neoducts on the basis of the individually (per structure)
applied score. Of the two other possible explanations, namely
that the unclassifiable structures correspond to acini (original-
ly lacking elastic fibres) or ducts losing their elastic coating,
the first seems unlikely due to the diffuse and non-lobular
distribution of these structures (this is why they could not be
classified even as likely acini), whereas the second is also
questionable on the basis of the distribution (there are too
many of them clustered close to each other, not allowing their
classification even as likely ducts).
Our study therefore identifies possible neoducts as struc-
tures devoid of elastic periductal fibres and most of the struc-
tures that could not be classified as (likely) ducts or (likely)
acini on the basis of distribution patterns as similarly devoid of
elastic fibres and possibly also as neoducts. The use of elastic
stains may probably be an aid in the study of neoductgenesis.
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